CALLODINE CAPITAL MANAGEMENT LP
Q3 2022 Form 13-F

BOSTON, MASSACHUSETTS
CIK 0001741675 · CRD 297115 · SEC-registered investment adviser
$321.5M Reported Value Total

CALLODINE CAPITAL MANAGEMENT reports 6 total accounts under management (AUM). There are 6 discretionary accounts valued at $513,492,630, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
3 funds · $1.0B gross asset value
Hedge Fund: $903.3M · Other: $117.9M
Source: Form ADV filed 2026-09-15
Reported value
$321.5M
Quarter over quarter
-9.6%
Holdings
44
Top-10 concentration
51.4%

Filing Structure

Reports holdings for

Key People

Form ADV owners & control persons
James Stuart Morrow
MANAGING MEMBER
Kristen Marie Cammarata
CHIEF COMPLIANCE OFFICER
William Karim
GENERAL COUNSEL

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2022 13F record

Q3 2022 13F filing summary

Q3 2022 Form 13F portfolio summary
Period of report September 30, 2022
Filed November 14, 2022
Form 13F-HR
Reported value $321.5M
Positions 44
Change in reported value -4.7%
New positions 3
Exited positions 8
Position turnover 21.2%
Top-10 concentration 51.4%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
62 $1.5B
Q1 2026 13F
Filed May 15, 2026
55 $1.4B
Q4 2025 13F
Filed Feb 13, 2026
52 $1.2B
Q3 2025 13F
Filed Nov 13, 2025
53 $1.1B
Q2 2025 13F
Filed Aug 13, 2025
47 $965.7M
Q1 2025 13F
Filed May 14, 2025
43 $601.2M
Q4 2024 13F
Filed Feb 13, 2025
42 $484.3M
Q3 2024 13F
Filed Nov 13, 2024
42 $479.6M
Q2 2024 13F
Filed Aug 13, 2024
42 $428.7M
Q1 2024 13F
Filed May 14, 2024
37 $413.3M
Q4 2023 13F
Filed Feb 14, 2024
37 $379.7M
Q3 2023 13F
Filed Nov 13, 2023
42 $358.7M
Q2 2023 13F
Filed Aug 14, 2023
36 $348.3M
Q1 2023 13F
Filed May 12, 2023
45 $339.0M
Q4 2022 13F
Filed Feb 13, 2023
42 $335.9M
Q3 2022 13F
Filed Nov 14, 2022
44 $321.5M
Q2 2022 13F
Filed Aug 12, 2022
49 $337.5M
Q1 2022 13F
Filed May 13, 2022
42 $311.5M
Q4 2021 13F
Filed Feb 14, 2022
36 $258.0M
Q3 2021 13F
Filed Nov 12, 2021
42 $265.5M

11 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2022

Largest Q3 2022 13F positions by reported value
# Holding Reported value % of portfolio
1 BXSL Blackstone Secured Lending Fund $22.9M 7.12%
2 TSLX Sixth Street Specialty Lending Inc $20.0M 6.22%
3 BBDC Barings BDC Inc $19.6M 6.11%
4 RDN Radian Group Inc $16.6M 5.18%
5 MRK Merck & Co Inc $15.1M 4.71%
6 KKR KKR & Co Inc $15.1M 4.68%
7 VTRS Viatris Inc $14.7M 4.56%
8 EQH Equitable Holdings Inc $14.1M 4.38%
9 ARES Ares Management Corp $13.9M 4.34%
10 VST Vistra Corp $13.2M 4.12%
11 BMY Bristol-Myers Squibb Co $11.7M 3.65%
12 SNY Sanofi SA $11.4M 3.55%
13 MO Altria Group Inc $11.1M 3.45%
14 MPW Medical Properties Trust Inc $10.5M 3.26%
15 PNNT Pennantpark Investment Corp $10.0M 3.12%
16 OWL Blue Owl Capital Inc $9.6M 2.98%
17 TRIN Trinity Capital Inc $9.2M 2.87%
18 LEN Lennar Corp $8.6M 2.67%
19 FSK FS KKR Capital Corp $6.4M 1.98%
20 CCI Crown Castle Inc $6.1M 1.91%

Values as reported on the Q3 2022 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings